CANF R&D Expenses
Can-Fite Biopharma Ltd American Depositary Shares, each representing two (2) Ordinary Shares · R&D Expenses
CANF R&D Expenses
Latest reported$7.12Mperiod ending
CANF R&D Expenses ($2.82M → $7.12M)
Annual R&D Expenses
High-resolution chart · PNG
CANF r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 6,746,095 | |
| 5,757,000 | |
| 5,983,000 | |
| 7,763,000 | |
| 9,850,000 | |
| 11,951,000 | |
| 10,976,000 | |
| 6,075,000 | |
| 5,271,607 | |
| 6,078,094 | |
| 3,855,868 | |
| 4,160,321 | |
| 4,419,239 | |
| 3,522,540 | |
| 3,407,514 | |
| 2,816,524 |